Andreas Bilstein,Hans-Joachim Galla,Mridula Dwivedi
申请号：
US15312970
公开号：
US20170173012A1
申请日:
2015.05.22
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention relates to a composition containing, as active ingredient, ectoine, hydroxyectoine and/or salts, esters or amides of these compounds for the treatment and/or prophylaxis of diseases of the eye that are associated with a disturbance of the tear film. The disease can be in particular a keratoconjunctivitis sicca. It has been found that, surprisingly, these compounds are capable of preventing a rupture in the outer lipid layer of the tear film, avoiding an undesirably rapid evaporation of the lacrimal fluid.
